RG
PRAH

Renaissance Group’s PRA Health Sciences, Inc. PRAH Stock Holding History

Renaissance Group’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-7,943
Closed -$1.22M – 295
2021
Q1 		$1.22M Buy
7,943
+65
+0.8% +$8.83K 0.05% 139
2020
Q4 		$988K Buy
7,878
+260
+3% +$29.1K 0.04% 151
2020
Q3 		$773K Buy
7,618
+37
+0.5% +$3.77K 0.04% 151
2020
Q2 		$738K Sell
7,581
-65
-0.9% -$6.05K 0.04% 155
2020
Q1 		$635K Buy
7,646
+469
+7% +$45.7K 0.04% 150
2019
Q4 		$798K Buy
7,177
+2,001
+39% +$206K 0.03% 159
2019
Q3 		$514K Buy
5,176
+29
+0.6% +$2.88K 0.02% 195
2019
Q2 		$510K Sell
5,147
-79
-2% -$7.54K 0.02% 204
2019
Q1 		$576K Sell
5,226
-319
-6% -$33.3K 0.02% 182
2018
Q4 		$510K Sell
5,545
-406
-7% -$41.1K 0.02% 192
2018
Q3 		$656K Buy
5,951
+165
+3% +$17.2K 0.02% 186
2018
Q2 		$540K Buy
5,786
+373
+7% +$32.1K 0.02% 197
2018
Q1 		$449K Buy
5,413
+149
+3% +$13.2K 0.02% 205
2017
Q4 		$479K Buy
5,264
+23
+0.4% +$1.91K 0.02% 189
2017
Q3 		$399K Buy
5,241
+2
+0% +$151 0.01% 216
2017
Q2 		$393K Buy
5,239
+126
+2% +$8.73K 0.01% 201
2017
Q1 		$334K Buy
+5,113
New +$301K 0.01% 225

Other funds holding PRAH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Renaissance Group's PRAH Position: Q2 2021 in Review

Renaissance Group sold out of PRA Health Sciences, Inc. (PRAH) in Q2 2021, closing a stake of 7,943 shares — an estimated $1.22M sold.

Renaissance Group first reported a position in PRAH in Q1 2017 and held it in 17 quarters. The position peaked at $1.22M in Q1 2021. 317 funds tracked by Wall St. Rank hold PRAH as of Q2 2021.

  • Renaissance Group reported no remaining PRA Health Sciences, Inc. position as of Q2 2021 after selling out during the quarter.
  • Renaissance Group sold 7,943 PRA Health Sciences, Inc. shares in Q2 2021, an estimated $1.22M.
  • Renaissance Group first reported a position in PRA Health Sciences, Inc. in Q1 2017 and held it in 17 quarters.
  • Renaissance Group's PRA Health Sciences, Inc. position peaked at $1.22M in Q1 2021.
  • 317 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q2 2021.

Based on Renaissance Group's 13F filing for Q2 2021, filed 13 Aug 2021.